Targeting HER3 in NSCLC
Therapeutic Relevance of HER3 in EGFR TKI-Resistant NSCLC

Released: April 03, 2023

Yasushi Goto
Yasushi Goto, MD, PhD

Activity

Progress
1
Course Completed